Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Autoclave Manufacturers Make False Claims About FDA Approvals
  • USA - English


News provided by

Revolutionary Science

Jul 16, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

The Saniclave 200, An example of an FDA Approved autoclave
The Saniclave 200, An example of an FDA Approved autoclave

Imported, non-FDA approved units are available on eBay at prices ranging from only a few hundred, to a few thousand dollars. Some even claim to be approved for medical use

Post this

Minneapolis, MN (PRWEB) July 16, 2013 -- Dental offices, medical clinics and even tattoo and nail salons are being required to use FDA cleared (approved) steam autoclaves, like the Tuttnauer Elara or the Saniclave 200 (retailing currently at about $999). Steam autoclaves such as these are highly regulated and have long been proven to be the most effective way to prevent the transmission of harmful pathogens. Recently, the sterilizer industry has seen the emergence of a disturbing trend, the profusion of small, unregulated autoclaves, almost all of which are being manufactured in China and distributed on Ebay.

"The problem with unregulated sterilizers is that they do not comply with the strict standards and sterilization cycle times that FDA approved autoclaves are forced to meet." Don Tumminelli, manager of Highpower Labs, and a voting member of the ANSI/AAMI ST55 committee stated in an interview, "FDA cleared devices follow strict, comprehensive testing models. The testing data is reviewed and approved by FDA prior to marketing. Sterilizers which have not been subjected to the FDA 510K process and marketed in the US could compromise patient safety."

Distributors of these unregulated sterilizers have been found to intentionally use misleading language in eBay and Amazon ads, such as “Dental, Medical, Tattoo.” Many even dare to use the FDA's name in vague ways, implying FDA approval such as “This product complies with FDA standards...”

Although questionable, the danger of these non-FDA approved autoclaves is not due to a lack of craftsmanship or durability. The real danger lies in the serious liability risk they may pose. “The problem is that they have never passed the rigors of the FDA. Imagine what happens if your facility is inspected and the inspector sees that you are using an unregulated autoclave.” remarked Shane Balkowitsch, a registered nurse and CEO of Balkowitsch Enterprises.

So why are people purchasing these unregulated autoclaves? Price and misleading claims. "Imported, non-FDA approved autoclaves are available on eBay at prices ranging from only a few hundred, to a few thousand dollars. Some even claim to be approved for medical use," states Isaac Erickson of Revolutionary Science. “If you are interested in purchasing an autoclave, look it up by name, using the FDA's website. It is easy to do and can prevent a nightmare down the road.”

The O'Ryan Omega ST is a non-FDA approved product that was actively marketed in the US for over a year, primarily to dentists, tattooists and small medical clinics. After a surprise FDA inspection, the Agency issued a warning letter (SEA 08-28) and the distributor was forced to cease all marketing of the device, states the investigations letter found on the FDA's website. Unfortunately, by this point dozens of Omega ST sterilizers were already sold to the clinical market in the United States. “A clinic can put their patients at risk when using an unregulated autoclave.” adds Chuck Fishelson, a veteran expert in the field and vice president of Alfa Medical.

One of the bigger problems with these devices is that they hold obscure sterilization cycle times. FDA approved autoclaves typically have a standard sterilization cycle of 121C for 30 minutes - the hospital standard. This cycle is long enough to kill the AIDS virus, “MSRA, the flesh eating disease” and all other known pathogens. Obscure, unregulated autoclaves rarely share this standard and rather tend to vary from manufacturer to manufacturer.

Servicing a non-FDA approved, foreign autoclave is also problematic. Replacement parts for foreign or non-FDA approved devices have to be ordered from the manufacturer or parts supplier. They are often located in China and can be troublesome and expensive to obtain. Calibration procedures are also difficult because these companies rarely have US representatives.

For more information on FDA approved sterilizers, such as the Revolutionary Science Saniclave 200, Scican Statim or the Tuttnauer Elara 9; or to check if an autoclave is approved, visit the FDA's website at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
About Revolutionary Science

In 1999, Revolutionary Science was founded after the birth of the company's first micro centrifuge. Years later, Revolutionary Science designs and manufactures incubators, centrifuges, autoclaves, automated cell and colony counters and water baths.

Registered with the FDA and ISO, Revolutionary Science is a Minnesota company dedicated to the manufacturing of precision life science and sterilization equipment.

Isaac Erickson, Revolutionary Science, http://www.revsci.com, 651-353-7806, [email protected]

Modal title

Saniclave 200 510k Summary
View PDF
Saniclave 200 510k Summary
Saniclave 200 510k Summary

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.